...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

Re: Resverlogix Reaches Agreement With FDA for Key Aspects of Apabetalone Registration Enabling Study

posted on Jun 22, 2020 09:32AM

"Can you see any possible strategic possibilities as to why more in depth details have not been released?"

I'mĀ assuming that you are talking about BETonMACE2 design details. They are still in the planning stages and things are likely in flux. Concrete details will be disclosed closer to trial initiation. Very likely many facets are still undecided.

BDAZ

Share
New Message
Please login to post a reply